What’s newsworthy in the Trenton, N.J., and surrounding areas.
No new safety signals observed at Year 5 in the POETYK PSO long-term extension trial, consistent with the established Sotyktu safety profile Following five years of continuous Sotyktu treatment, clinical response was maintained in nearly half of patients for Psoriasis Area and
Results presented at the American Society of Clinical Oncology’s Genitourinary Cancers Symposium (ASCO GU 2025) Treatment with UGN-102 resulted in durable complete response (CR) rates across subgroups with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) CR rates were: 82.8% for patients
EWING, N.J. — (BUSINESS WIRE) — Church & Dwight Co., Inc. (NYSE: CHD) will present at the 2025 Consumer Analyst Group of New York (CAGNY) Conference on Thursday, Feb. 20, 2025, at 4 p.m. EST. The presentation will be broadcast on the
Rebecca W. Flemer, M.S., Historic Preservation, University of Pennsylvania, will share research from her work life with historic gardens on landscaping and gardens of the 1820’s at a special program, Saturday, Feb. 22, at 2 p.m. at the Discovery Center at Point
EWING, N.J. — (BUSINESS WIRE) — Cenlar FSB, the nation’s leading mortgage loan subservicer, announced Monday the promotion of Tom Donatacci to Senior Vice President, Chief Client Officer, overseeing Business Development and Client Management. A recognized and highly accomplished leader in the
Patients experienced a 38% reduction in the risk of disease progression or death when treated with Opdivo plus Yervoy versus Opdivo monotherapy across all lines of therapy at median 47 months of follow-up Late-breaking data presented in oral session at the 2025
Hezi Saar of Synopsys appointed board chair; new vice chair and treasurer named for global organization developing interface specifications for mobile, IoT, automotive and related industries BRIDGEWATER, N.J. — (BUSINESS WIRE) — #IoT — The MIPI Alliance, an international organization
Components will be the first-in-human use of OSTAGUARD™ PRINCETON, N.J. — (BUSINESS WIRE) — Orthobond Corporation, a leader in covalently-bound antibacterial surface technologies with broad applications in the medical device industry, today announced the successful in-house production and commercial delivery
PRINCETON, N.J. — (BUSINESS WIRE) — #AAC — Lingraphica, a leader in augmentative and alternative communication (AAC) devices, announced a significant leadership transition. Current Chief Operating Officer Kevin Self has assumed the role of Chief Executive Officer effective Jan. 1, 2025. He